TWiV 934: Clinical update with Dr. Daniel Griffin

In his weekly clinical update Dr. Griffin discusses variant influenza virus infections: recommendations for identification, treatment, and prevention for summer and fall 2022, low levels of monkeypox virus neutralizing antibodies after MVA-BN vaccination in healthy individuals, using the right tools at the right time for SARS-COV-2 infection, onset and window of SARS-COV-2 infectiousness and temporal correlation with symptom onset, transmission of SARS-COV-2: a review of viral, host, and environmental factors, antibody persistence and safety through 6 months after heterologous orally aerosolized Ad5-nCoV in individuals primed with two-dose vaccine, timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients, administration of anti–SARS-COV-2 monoclonal antibodies after US Food and Drug Administration deauthorization, and clinical and genetic risk factors for acute incident venous thromboembolism in ambulatory patients with COVID-19. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode 2022 recommendations for Influenza infections (CDC) Low levels of monkeypox neutralizing antibodies after vaccination (medRxiv) Using the right tools during SARS-CoV-2 infection (ESMED) Onset and window of SARS-CoV-2 infectiousness with symptom onset (The LANCET) Transmission of SARS-COV-2 (ACP Journals) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for pr...
Source: This Week in Virology - MP3 Edition - Category: Virology Authors: Source Type: podcasts